CorMedix Inc.

Cormedix Inc.

Biotechnology Healthcare Berkeley Heights, NJ, United States CRMD (NGM)

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has CorMedix Inc. had layoffs?
No layoff events have been recorded for CorMedix Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CorMedix Inc. have?
CorMedix Inc. has approximately 64 employees.
What industry is CorMedix Inc. in?
CorMedix Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is CorMedix Inc. a publicly traded company?
Yes, CorMedix Inc. is publicly traded under the ticker symbol CRMD on the NGM. The company has a market capitalization of approximately $1.00 billion.
Where is CorMedix Inc. headquartered?
CorMedix Inc. is headquartered in Berkeley Heights, NJ, United States at 300 Connell Drive, Berkeley Heights, NJ 07922, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.